Public Policy 

The Colorado BioScience Association (CBSA) has been driving advocacy and public policy initiatives since its founding in 2003. A respected voice a the State Capitol and in Washington D.C., CBSA has been successful in working collaboratively to pass legislation that is positive for the industry while working to defeat proposals that would be detrimental to the bioscience industry in Colorado. CBSA is committed to maintaining an ongoing dialogue with key members of the state legislature, Colorado’s congressional delegation and the Governor’s office in order to support the creation, retention and recruitment of bioscience companies and promoting Colorado as a premier life sciences cluster.

Advocacy Partnerships

CBSA works closely with national organizations such as the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association ( MDMA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) to advocate for shared policy objectives to ensure that Colorado companies' voices are heard by federal elected officials. 

CBSA consistently is ranked as one of the states with the best advocacy initiatives – and success – by the Biotechnology Industry Organization when compared to all bioscience trade associations across the U.S.

Legislative Resources

Colorado General Assembly
Includes contact information for Colorado legislators, legislative staff and updates on pending legislation.

CBSA State Policy Priorities
Provides an overview of the policy initiatives CBSA is engaged on at the state level.

CBSA Federal Policy Priorities
Provides and overview of the federal policy priorities CBSA is engaged in at the federal level.

Please direct questions to Jennifer Jones, Vice President of Colorado BioScience Association.